Hepatic repercussions of azoxymethane-induced colorectal carcinogenesis. 2013

Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
Post-Graduation Program, Federal University of Ceará, Fortaleza, Ceará State, Brazil. idaliaburlamaqui87@hotmail.com

OBJECTIVE To evaluate the hepatic effects of colonic carcinogenesis induced by azoxymethane at different doses and times of exposure in rats. METHODS Forty-four Wistar rats were divided into four groups. The animals were eight weeks at the beginning of the experiment. group 1 received 1.0 ml of saline intraperitoneally once a week for two weeks. Group 2 received 15 mg/kg of azoxymethane intraperitoneally once a week for two weeks. These animals were killed at the 15th week of the experiment. The animals of group 3 received saline intraperitoneally once a week for two weeks. Group 4 animals received 20mg/kg of azoxymethane intraperitoneally once a week for two weeks. These animals were killed at the 26th week of the experiment. The fragments of liver tissue were stained with hematoxylin and eosin and evaluated microscopically. RESULTS Groups 1 and 2 differed significantly in relation to steatosis, no difference having been found between group 3 and group 4. However, in group 4 we observed pre-neoplastic lesions (foci of altered, clear, vacuolated, basophilic, amphophilic tigroid, oncocytic, small or acidophilus cells, spongiosis and peliosis) and neoplastic lesions (adenomas and colangiomas) containing atypical hepatocytes in between, not identified in group 3. CONCLUSIONS In the model of colorectal carcinogenesis, preneoplastic and neoplastic hepatic lesions appear and evolve in proportion to the time of exposure and dose of azoxymethane.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001397 Azoxymethane A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas.
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D063646 Carcinogenesis The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years. Tumorigenesis,Oncogenesis,Carcinogeneses,Oncogeneses,Tumorigeneses

Related Publications

Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
November 1993, Gut,
Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
August 2011, International journal of cancer,
Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
August 2014, Journal of medicinal food,
Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
January 1999, Oncology reports,
Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
November 2008, World journal of gastroenterology,
Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
June 1998, British journal of cancer,
Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
November 2006, The Journal of nutrition,
Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
March 2015, Nutrients,
Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
July 2013, Cancer science,
Idália Maria Brasil Burlamaqui, and Conceição Aparecida Dornelas, and Paulo Roberto Carvalho Almeida, and Francisco Vagnaldo Fechine Jamacaru, and Daniel Magalhães Coutinho Mota, and Francisco José Cabral Mesquita, and Lara Albuquerque de Brito, and Lara Burlamaqui Veras, and Lusmar Veras Rodrigues
June 2019, Cancer prevention research (Philadelphia, Pa.),
Copied contents to your clipboard!